EcoDrugPlus

Carbonic Anhydrase Ii

Ensembl ID : ENSBTAG00000017733
Gene Symbol: CA2
6 Enzyme and pathways 4 Cross references
297 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSBTAG00000047582
Gene Symbol: CSNK1E
24 Enzyme and pathways 4 Cross references
276 Possible Orthologues:

Casein Kinase 2 Alpha 1

Ensembl ID : ENSBTAG00000012341
Gene Symbol: CSNK2A1
35 Enzyme and pathways 4 Cross references
150 Possible Orthologues:

Caspase 1

Ensembl ID : ENSBTAG00000050239
Gene Symbol: CASP1
9 Enzyme and pathways 5 Cross references
472 Possible Orthologues:

Caspase 8

Ensembl ID : ENSBTAG00000015718
Gene Symbol: CASP8
49 Enzyme and pathways 5 Cross references
144 Possible Orthologues:

Caspase 9

Ensembl ID : ENSBTAG00000002472
Gene Symbol: CASP9
10 Enzyme and pathways 5 Cross references
216 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSBTAG00000019516
Gene Symbol: COMT
10 Enzyme and pathways 5 Cross references
289 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSBTAG00000011100
Gene Symbol: CTSC
14 Enzyme and pathways 5 Cross references
247 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSBTAG00000021035
Gene Symbol: CTSK
15 Enzyme and pathways 5 Cross references
252 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSBTAG00000017135
Gene Symbol: CTSS
9 Enzyme and pathways 5 Cross references
282 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSBTAG00000016307
Gene Symbol: CDC7
10 Enzyme and pathways 5 Cross references
221 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSBTAG00000017582
Gene Symbol: CHEK1
5 Cross references
190 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).